Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

Eli Lilly and Novo Nordisk are boosting supply of their weight loss drugs, while Apple Watch's heart monitoring tech was approved for use in clinical studies.

from International: Top News And Analysis https://ift.tt/xsmWG7h